chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (experienced in February 2020). Concurrent medical conditions included colorectal cancer (survivor missing 36 lymph missing). Concomitant products included valaciclovir hydrochloride (Valtrex) and gabapentin.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The case was reported by the spouse of the patient. The age at vaccination was not reported, however could be 58 or 59 years. The patient experienced shingles in February 2020, after healing, the patient took his 1st Shingrix vaccine. Valtrex was used as a treatment for shingles. The reporter consented to follow up. For tolerance of 2nd dose, refer case US2021018356.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021018356:Same patient 2nd dose
Shingrix was administered intended as a first dose and was later discover a dose of shingrix may have been administered 1 month before that; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number G3T43, expiry date 07-JUL-2024) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 21-MAR-2023, the patient received the 2nd dose of Shingrix. On 21-MAR-2023, an unknown time after receiving Shingrix and an unknown time after receiving SHINGRIX, the patient experienced drug dose administration interval too short (Verbatim: Shingrix was administered intended as a first dose and was later discover a dose of shingrix may have been administered 1 month before that). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 14-JUN-2023 The reporter reported a dose of Shingrix was administered intended as a first dose and was later discover a dose of Shingrix might had been administered 1 month before that.  The reporter was unsure if that first dose was administered because of little documentation about it and patient was unsure if it was administered or not. The dose discovered on the patient´s record only was documented to have been administered on 22nd February 2023 but had no lot number or name of the person who administered the dose, healthcare professional also confirmed with patient and doctor office and no one had information of this dose occurring. The reporter was reporting proactively because healthcare professional was unsure if the dose was administered or not. The reporter did not consent to follow-up. The patient received 2nd dose of Shingrix earlier than the recommended schedule, which led to shortening of vaccination schedule.
approx 1 1/2hr p/vax pt had 4-5hr constant, high pitch shrill cry;no other effects;
3 weeks post flu shot in (R) deltoid experienced muscle weakness B/L legs. Has progressively gotten worse. Walks with a limp. Multiple cat scans and spinal tap-Questionable ALS?? Continues to follow up with neurologist.
Severe headache started about 20 mins after vaccine, fever started the next day along with  extreme achiness.  Fever went back to normal in about 24 hours.  Fever started again 12 hours later.  Headache is still there, but mild.
felt a little bit of ache; felt cold/was freezing to death; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt a little bit of ache) and FEELING COLD (felt cold/was freezing to death) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced PAIN (felt a little bit of ache) and FEELING COLD (felt cold/was freezing to death). At the time of the report, PAIN (felt a little bit of ache) and FEELING COLD (felt cold/was freezing to death) outcome was unknown.            Patient has no side effects after receiving first dose.  No concomitant medications were reported. No treatment medications were reported.
I received the second dose of Pfizer-Bioteck Covid19 vaccine on Jan 14th.  The next day, I had soreness at the vaccine site, headache and fatigue all day.  Then, the following day, when I woke up I started itching all over my body and I had hives.  I have chronic uticaria(hives) for over 40 years and it has got better as I age.  The hives I got this time is different from my chronic hives in that scratched area stayed red for hours and did not go away.  The part I scratched hard kept raised and itchyness came back for several times. This hive almost lasted for 2 days and I took benadryl for  3-4 times. I did not see any doctor for this hives.  My chronic hives usually last short period of time..itchy spots last for 10-15 mins, it become red and raised. But my skin usually turns normal after 15-20 mins.  So this hives are different from my chronic hives and I considered it's from the COVID vaccine.
Pt recvd 1 dose of Engerix-B on 25SEP91 & 1wk p/1st dose pt exp tingling primarily on lt arm which radiated to legs & arms; events lasted about 2 wks;
After receiving  Moderna Covid vaccine (047B21A) my brother became ill. He had to be hospitalized for Pancreatitis. He was treated by a Doctor after and never recovered. He passed away on 9/15/21.
No additional adverse events reported; an expired dose of MMR II was given; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.       On 23-JUN-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (1 dose, lot # S018595, expiration date 17-JUN-2021; strength, route of administration and anatomical location were not reported ) for prophylaxis (expired product administered). The dose was properly stored up through the time of administration and had not experienced any temperature excursions. No additional adverse events were reported (no adverse event). No product quality complaint.
11/26/01 Fever 102. Patient also seemed agitated. Took to doctor on 11/28/01; developed a cold and crying. 12/26/01 cold still, raspy voice, taking Amoxil; fever down 100.5. 1/10/02 cold still. 1/25/02 cold still; taking Zyrtec. 2/2/02 Switched doctors; took off milk and cleared up in 3 days. 2/12/02 Pneumonia; Biavil. The 60 day follow up received on 12/24/03 states autism diagnosis 7/15/03. Areas of concern: communication, imitation skills (motor and vocal), transitions and following one step directions. marked impairment in the use of multiple nonverbal behaviors. Lack of spontaneous seeking to share enjoyment, interests or achievements with others. Lack of social or emotional reciprocity. Delay in or total lack of development of spoken language. Lack of varied, spontaneous make-believe or social imitative play. Encompassing preoccupation with interest that is abnormal in intensity or focus. Stereotyped and repetitive motor mannerism for walking, hair twirling. Persistent preoccupation with parts of objects (visual inspection).   Nurse follow up on 08/19/04 states: "autism; Language disorder."
PATIENT WAS ACCIDENTALLY GIVEN A 3RD DOSE OF MODERNA COVID VACCINE RATHER THAN HER 2ND DOSE OF SHINGRIX.  NO ADVERSE EVENT REPORTED YET.  PATIENT WILL WAIT 2 WEEKS TO RECIEVE 2ND SHINGRIX DOSE.
The patient did not have an adverse health event. The wrong dose of covid vaccine was given to the patient with no harm caused towards the patient.
60 hours of intense muscle aches and pains, headache and joint pain. Extreme fatigue.
Site: Pain at Injection Site-Mild, Systemic: Confusion-Mild, Systemic: Fainting / Unresponsive-Medium
Within an hour was feeling jumpy, easily startled, foggy thinking, fever (highest 101.6 normal temp is 97.5), unable to sleep for over 2 days (still haven?t slept partly due to extreme pain), extreme pain all over body especially on left side, racing heart (103 while laying down normal resting is 78), fever would not go down with any amount of fever reducer for 2 days (starting to slowly go down), sore throat, swelling in ankles and feet for two days (is going down now), congested nose, severe ear pain, joint stiffness and extreme ache.  Itchy all over body and rash on back. I received the vaccine on 1/20 it is now 1/22 and most are still present though some are getting better very slowly. I did not seek medical care as no one would see me so I just have isolated myself and checked in with a good friend regularly. I just felt it important to report this as no one warns how bad the reaction may be and unlike with the first dose, absolutely no check ins from hospital. I find that to be completely unacceptable.
Severe arm, shoulder, neck pain onset followed immediately by dizziness, faintness, light-headedness and nausea. Event lasted appx 45 minutes.
I got these reaction every time, every time I have gotten COVID Vaccine I have gotten sick; I had Moderna, moderna, Pfizer, Pfizer, Pfizer; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 63-year-old female patient received BNT162b2 (BNT162B2), on 17Nov2021 as dose 3 (booster), single (Lot number: FH8027) at the age of 63 years for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Seasonal allergy" (unspecified if ongoing). Concomitant medication(s) included: MONTELUKAST SODIUM; LOSARTAN; NEBIVOLOL. Vaccination history included: moderna coviD-19 vaccine (DOSE 1, SINGLE, LOT#: 028L20A), administration date: 14Jan2021, when the patient was 62-year-old, for COVID-19 immunization, reaction(s): "sick"; moderna coviD-19 vaccine (DOSE 2, SINGLE, LOT#: 013M20A), administration date: 12Feb2021, when the patient was 62-year-old, for COVID-19 immunization, reaction(s): "sick". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 17Nov2021, outcome "unknown", described as "I had Moderna, moderna, Pfizer, Pfizer, Pfizer"; ILLNESS (non-serious), outcome "unknown", described as "I got these reaction every time, every time I have gotten COVID Vaccine I have gotten sick".  Additional information: Additional information: Investigation was none. No Prior vaccinations within 4 weeks. Patient stated, "she had 5th COVID (Pfizer COVID-19 Vaccine) shot Saturday and just like all the other time, she got sick from Saturday night all day yesterday, she was almost back to normal on the day of reporting. The person exactly encourages people to get these vaccines 'then' you have fever, chills and burn ache. So, that's why the patient was calling. She further stated, "she got these reactions every time, every time she has gotten COVID Vaccine she has gotten sick. Sender's Comments: Linked Report(s): US-PFIZER INC-202300177411 same patient/vaccine, diff dose/event; US-PFIZER INC-202300177316 same patient/vaccine, diff dose/event;
Headache, rash on torso, itching at various spots, spots which then got scabs on them showed up on 1 DEC 12 to  3 DEC 12 on left leg.
This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose Jan 28 2021 and second dose on Feb 21 2021) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006m20a and 029l20a) for COVID-19 vaccination.     Concomitant products included PREDNISONE, METOPROLOL, TAMSULOSIN and CALCIUM for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose Jan 28 2021 and second dose on Feb 21 2021). On 21-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose Jan 28 2021 and second dose on Feb 21 2021) had resolved.            The patient received booster dose on 17-Nov-2021 (lot number 018f21a).  No treatment information was reported.   This case was linked to MOD-2021-392007 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Follow up document contains no new information
Flu-like symptoms, increasing in intensity over the following weeks. Fevers up to 101.8 F., reduced by Tylenol.  Increasing dry, upper respiratory cough. Extreme lethargy & loss of appetite. Patient has lost 9-10 pounds. Blood oxygen ok nominally 86% throughout. As of this date - fever spikes less frequent. Some appetite returning.
No adverse event; 7 years old patient received a half dose of the Moderna COVID-19 vaccine by intramuscular injection as a booster; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (7 years old patient received a half dose of the Moderna COVID-19 vaccine by intramuscular injection as a booster) and NO ADVERSE EVENT (No adverse event) in a 7-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 Vaccine on 09-Nov-2021 and Pfizer COVID-19 Vaccine on 30-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 Vaccine and Pfizer COVID-19 Vaccine.    On 06-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 06-Aug-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (7 years old patient received a half dose of the Moderna COVID-19 vaccine by intramuscular injection as a booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (7 years old patient received a half dose of the Moderna COVID-19 vaccine by intramuscular injection as a booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (7 years old patient received a half dose of the Moderna COVID-19 vaccine by intramuscular injection as a booster).    It was reported that patient received half dose of Moderna COVID-19 vaccine as a booster. Concomitant drugs were not reported. It was also reported that patient did not experienced any symptoms after receiving this dose of the vaccine and no additional doses, medications, or treatments have been administered in response to this event.
Severe itching and Burning on arms, back of Hands, neck and face. rubbed off eye lashes and eye brows has gone on for months up to today I have used all kinds of lotions to stop this but I can't.
A report has been received from a health professional concerning a child of unknown age and gender. No medical history, concomitant diseases and concomitant medications were reported for consumer. Patient had received FLUMIST QUADRIVALENT (intranasal) started during Oct-2014. A week later of administration of vaccine, patient had come in for a doctor's visit due to having sore throat and aching symptoms, Streptococcus swab/culture result was negative. Influenza swab/culture result was positive. Patient was diagnosed with influenza and received general care instructions to follow up in home. The outcome of the event of child received FLUMIST on October 2014 and then tested positive for influenza with aching symptoms was unknown. The report was considered to be non-serious by reporter.
Patient with a history of burning and burning sensation - felt like I had a scratch under my wrist watch that began on his left wrist 2 days post multiple vaccines. The sensation greatly increased after receiving smallpox vaccine 1 week later now radiating from his lower back, spreading across is abdomen, lower chest and down into his legs. The burning became increasingly painful over several days until by 6/22 it was unbearable (11/10 on pain scale) and he sought medical care for pain medication and was treated with IV steroids. He returned 2-3 days alter complaining of difficulty urinating. "I was drinking lots of fluid" with no urinary output in 12 hours. He was placed on 20 day oral steroid taper with some improvement in his symptoms and deployed. Once there his symptoms again progressed to include lower extremity weakness and difficulty walking. He was subsequently transported to a hospital and from there to another hospital on 8/13/05. Per follow up report- Service member says that he is feeling better, although he still has some burning and tingling in his lower back and legs and to a lesser extent, in his arms and hands.  He is completely self sufficient in giving himself his weekly Avenox injections and says he "feels pretty good" on the medication.  He says he doesn't tire as easily and noticed he can walk farther without having to stop and rest as often as before.  He still works out at the gym daily and continues to coach.  He has an appointment to be seen by Dr on 22 Nov 05 for follow up and review of his labs (CBC and CMP) done the end of October.  It was suggested during the Vaccine Healthcare Center's Neurological Conference, that a serum antibody (NMO-IgG) ordered through the facility might help to differentiate between Devic's disease and MS.  Service member plans to discuss this test with his doctor during his next appointment.
On 06/18/2022 and 06/19/2022 I took a home test and both were negative. I retested on 06/20/2022 and was positive.  The only thing I had was a really sore throat, dry cough and felt tired for the first day or so. I received a prescription for PAXLOVID 06/20/2022 and started taking it the same day. I was symptom free by Wednesday morning and tested negative the following Sunday the 26th.
her arm was sore near the injection site; then the soreness spread to her shoulder; she can barely move her arm and shoulder; She added she is in "excruciating pain";; it is "terrible" and "debilitating".; her arm pain; This is a spontaneous report from a contactable consumer (reporting for herself). A 79-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 26Feb2021 as single dose for covid-19 immunisation. Patient medical history included spinal stenosis from an unknown date and unknown if ongoing. Patient concomitant medications were not reported. Patient persistently asked what to do to manage her symptoms from the Pfizer-BioNTech COVID-19 vaccine. She explained her doctor said he cannot help and has not seen this before.  She then threatened to call her lawyer if a doctor or scientist from the company could not assist her. It was stated that patient received the second dose of the Pfizer-BioNTech COVID-19 vaccine on 26Feb2021. She explained a few days after, her arm was sore near the injection site, then the soreness spread to her shoulder and she can barely move her arm and shoulder. She added she was in excruciating pain; it is terrible and debilitating. She took pain medicine for the arthritis in back and described it as spinal stenosis. She mentioned this medication was barely doing something to help with her arm pain. She then specified she also consulted her doctor who prescribed gabapentin and methyl prednisone tablets, which aren't relieving her arm pain. She expressed her concerns on the persistence and intensity of her pain. She asked if her symptoms were reported as side effects to the vaccine. Patient expressed her disappointment on the lack of information provided to manage her symptoms from the Pfizer-BioNTech COVID-19 vaccine. She said she was excited to get this vaccine among the other brand, and now that she is injured from it, she feels like Pfizer should be by her side and thus claims to have help from Pfizer. Outcome of the event her arm pain and her arm were sore near the injection site was not recovered. Outcome of the other events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
PATIENT HAD SCRATCHY THROAT WITHIN 30 MINUTES OF VACCINATION PATIENT GIVEN BENADRYL 50MG INTRAMUSCULARLY
14 year old female with a CC of lightheadedness about 8 minutes after her first dose of Pfizer.  States she also noted mild nausea. I asked the patient to elevate her legs and she states her symptoms resolved. I also had the patient drink more water at that time. No wheezing, no hives, no toungue, lips, or throat swelling. No vomiting. Vitals signs were stable, oxygen saturation 98%.  EMS was not called and mother and patient decided not to go to ED for follow-up as the patient has a history of vasovagal syncope around needles and states this response is normal for her.
Symtoms of chronic fatigue, fibromyalgia, insomnia, migraine headache, TMJ disorder, Tinnitus, severe pain in neck, shoulders, back, numbness in arms, menstrual disorder, restless leg syndrome, rosacea. Tried physical therapy, chiropractic treatment, Doctors have thrown so many medications at me that I don't know where to begin. Currently taking Lyrica, Baclofen, restorol, sumatriptan, toradol.
on April 2nd patient woke up at around 4:30 am and complained of pain in his back. I rubbed his back and he wondered if it was just something he ate.  He then tried to calm down and got back into bed . He was holding my hand when suddenly his hand felt cold. I turned on the light to find his eyes rolled back and he was gasping his last breath . This was about 5:20 AM . Patient was a healthy active man.
Patient's received first dose of Moderna vaccine on 04/27/2021 (lot # 039B21).  Pfizer vaccine was administered for second dose on 06/12/2021.  Error was reported to patient immediately.  She reported no adverse symptoms after learning this.  Patient returned to mobile clinic escorted by fellow workers after an hour and reported having a head ache and blurry vision.  Vital signs were taken 142/87BP; 72 HR; 99% O2 sat.  She denied rash, pruritus, difficulty breathing, n/v.  She did not want to be seen at the ED and stated she was going to be alright.  Patient returned to mobile site at 3p reporting h/a and nausea. Patient vomited and  asked  for an ice pack for her head. Patient reported that she has hypothyroidism and has not taken her medication for almost 1 year.  Additionally, she reports a history of anxiety and PTSD.  Again Patient denied to be seen at the ED.  Patient was encouraged to be seen at the ED if her condition worsen.
PATIENT CALLED IN THE PHARMACY AND COMPLAINED ABOUT HAVING ITCHY AND BUMPY SKIN ON BOTH LEGS AND THIGHS. PATIENT HAVE ALREADY USED BENADRYL LIQUID.